TY - JOUR
T1 - Molecular mechanism of caffeine-aspirin interaction in kopi balur 1 as anti-inflammatory agent
T2 - A computational study
AU - Kharisma, Viol Dhea
AU - Ansori, Arif Nur Muhammad
AU - Fadholly, Amaq
AU - Sucipto, Teguh Hari
N1 - Publisher Copyright:
© 2020, Institute of Medico-Legal Publications. All rights reserved.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Balur treatment (BT) is a method that works to remove toxins in the form of free radicals released via the skin. One of the remedies used is Kopi Balur 1 (KB1) which contains aspirin and caffeine used during the BT, so that KB1 is believed to have the potential to reduce or inhibit the occurrence of inflammatory processes in the body. Therefore, we investigate the interactions that occur between ligands and proteins, predict the action mode of caffeine-aspirin contained in KB1 as an anti-inflammatory agent, and modeling the 3D structure of pro-inflammatory proteins in the human body. The target compound, aspirin-caffein, was obtained from a database, then used to identify the pathway on the STITCH webserver, then the target protein was obtained and modeled in 3D using the SWISS-MODEL webserver, and the structures obtained were represented in PyMol software. In sum, the aspirin-caffeine ligand complex contained in KB1 has the potential as an anti-inflammatory agent in the human body via the molecular mechanism of binding and inhibiting the biological activity of proinflammatory proteins, i.e. PTGS1, PTGS2, and ADOR2A.
AB - Balur treatment (BT) is a method that works to remove toxins in the form of free radicals released via the skin. One of the remedies used is Kopi Balur 1 (KB1) which contains aspirin and caffeine used during the BT, so that KB1 is believed to have the potential to reduce or inhibit the occurrence of inflammatory processes in the body. Therefore, we investigate the interactions that occur between ligands and proteins, predict the action mode of caffeine-aspirin contained in KB1 as an anti-inflammatory agent, and modeling the 3D structure of pro-inflammatory proteins in the human body. The target compound, aspirin-caffein, was obtained from a database, then used to identify the pathway on the STITCH webserver, then the target protein was obtained and modeled in 3D using the SWISS-MODEL webserver, and the structures obtained were represented in PyMol software. In sum, the aspirin-caffeine ligand complex contained in KB1 has the potential as an anti-inflammatory agent in the human body via the molecular mechanism of binding and inhibiting the biological activity of proinflammatory proteins, i.e. PTGS1, PTGS2, and ADOR2A.
KW - Anti-inflammatory agent
KW - Computational study
KW - Kopi balur 1
KW - Molecular mechanism
UR - http://www.scopus.com/inward/record.url?scp=85099436422&partnerID=8YFLogxK
U2 - 10.37506/ijfmt.v14i4.12274
DO - 10.37506/ijfmt.v14i4.12274
M3 - Article
AN - SCOPUS:85099436422
SN - 0973-9122
VL - 14
SP - 4040
EP - 4046
JO - Indian Journal of Forensic Medicine and Toxicology
JF - Indian Journal of Forensic Medicine and Toxicology
IS - 4
ER -